These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2480399)

  • 41. Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
    Kasarello K; Kwiatkowska-Patzer B; Lipkowski AW; Bardowski JK; Szczepankowska AK
    Med Sci Monit; 2015 May; 21():1587-97. PubMed ID: 26026273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of tetramisole on the induction of experimental allergic encephalomyelitis (EAE).
    Todorov DM; Michailov WG; Drumtcheva MA
    Allerg Immunol (Leipz); 1982; 28(3):192-6. PubMed ID: 6183965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A; Miller A; Santos LM; Weiner HL
    Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum lipids and demyelination in experimental allergic encephalomyelitis induced by the increased encephalitogenicity of myelin basic protein given with galactocerebrospide.
    Krzalić LJ; Nedeljković DR; Cvetković DH; Skender MK
    J Neuroimmunol; 1989 May; 22(3):193-9. PubMed ID: 2467917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myelin basic protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat.
    Zehetbauer B; Massacesi L; Liuzzi GM; Vergelli M; Olivotto J; Grassi L; Riccio P; Amaducci L
    Acta Neurol (Napoli); 1991 Apr; 13(2):121-32. PubMed ID: 1716398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental autoimmune encephalomyelitis: antigen-induced inhibition of biochemical and immunohistological alterations.
    Bucher AE; Maccioni M; Rivero VE; Riera CM; Roth GA
    J Neurosci Res; 1996 Nov; 46(3):367-74. PubMed ID: 8933376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE).
    Lisak RP; Zweiman B; Blanchard N; Rorke LB
    J Neurol Sci; 1983 Dec; 62(1-3):281-93. PubMed ID: 6199466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form.
    Massacesi L; Vergelli M; Zehetbauer B; Liuzzi GM; Olivotto J; Ballerini C; Uccelli A; Mancardi L; Riccio P; Amaducci L
    J Neurol Sci; 1993 Oct; 119(1):91-8. PubMed ID: 7504090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
    J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of anti-myelin antibodies in EAE and their possible role in demyelination.
    Sadler RH; Sommer MA; Forno LS; Smith ME
    J Neurosci Res; 1991 Dec; 30(4):616-24. PubMed ID: 1787538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of myelin proteins in multiple sclerosis brain tissue.
    Trotter JL; Wegescheide CL; Garvey WF; Tourtellotte WW
    Neurochem Res; 1984 Jan; 9(1):147-52. PubMed ID: 6201757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
    Strejan GH; Percy DH; St Louis J
    Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic experimental allergic encephalomyelitis and antibody responses in rabbits immunized with bovine proteolipid apoprotein.
    van der Veen RC; Sobel RA; Lees MB
    J Neuroimmunol; 1986 Jun; 11(4):321-33. PubMed ID: 2423554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.